NRG ONCOLOGY NRG-BN006: A PHASE II/III RANDOMIZED, OPEN-LABEL STUDY OF TOCA 511 AND TOCA FC WITH STANDARD OF CARE COMPARED TO STANDARD OF CARE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA Conference

Ahluwalia, Manmeet, Pugh, Stephanie, Ellingson, Benjamin et al. (2019). NRG ONCOLOGY NRG-BN006: A PHASE II/III RANDOMIZED, OPEN-LABEL STUDY OF TOCA 511 AND TOCA FC WITH STANDARD OF CARE COMPARED TO STANDARD OF CARE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA . NEURO-ONCOLOGY, 21 220-221.

cited authors

  • Ahluwalia, Manmeet; Pugh, Stephanie; Ellingson, Benjamin; Kotecha, Rupesh; Cloughesy, Timothy; Vogelbaum, Michael; Aldapec, Kenneth; Cu, Yunfeng; Armstrong, Terri; Mehta, Minesh

authors

date/time interval

  • November 20, 2019 -

publication date

  • November 1, 2019

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • AZ, Phoenix

Conference

  • 24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

publisher

  • OXFORD UNIV PRESS INC

start page

  • 220

end page

  • 221

volume

  • 21